• Latest Posts
More News! 14 Sep 2017

New Dutch Spin Out will Treat Stroke with RNA Therapy

Austrian Researchers build an improved Mini-Brain to support Psychiatry

UPDATE: UK Cannabis Biotech ready for a Blockbuster in Rare Epilepsy

Heptares receives €4.5M Milestone for New Migraine Drug Candidate

UPDATE: Italian Pharma receives €11M for Parkinson’s Drug Approval

Novartis Negotiates its Way into the US Migraine Market


New Grant to Advance a Whole New Treatment Against Parkinson’s in the UK

Interview 10 Apr 2017

“Alzheimer’s is the Last Unclaimed Therapeutic Space,” says TauRx exec

Can Roche & MorphoSys beat the odds in new Alzheimer’s Phase III Trials?

Galapagos finds a Partner to Boost its Pipeline with Drug Combinations

French Biotech bids for Crowdfunding in Neurodegenerative Disease

Biotech from the Bermuda Islands Brings Good News for Dementia Patients